Translational Drug Development, LLC
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
4
Ending by 2030
Jun 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 27, 2027The maintenance fee for Heterocyclic compounds as kinase inhibitors (US 10,392,402) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
- 1 fee due Mar 8, 2027The maintenance fee for 4-(benzimidazol-2-ylamino)benzamide derivatives and salts or solvates thereof (US 9,125,901) comes due Mar 8, 2027. Unpaid by Sep 8, 2027, it lapses early.
- 1 fee due Apr 10, 2027The maintenance fee for Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase (US 11,780,816) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
- 1 fee due Jun 29, 2027The maintenance fee for Benzamide derivatives (US 9,221,773) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
- 1 fee due Sep 17, 2027The maintenance fee for 4-(benzimidazol-2-ylamino)benzamide derivatives and methods of synthesis thereof (US 10,590,088) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
- 1 fee due Oct 28, 2027The maintenance fee for Heterocyclic compounds as kinase inhibitors (US 10,633,393) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,464,059 | Benzamide derivatives In force · From the USPTO record | In force | From the USPTO record | |
| US 10,590,088 | 4-(benzimidazol-2-ylamino)benzamide derivatives and methods of synthesis thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,125,901 | 4-(benzimidazol-2-ylamino)benzamide derivatives and salts or solvates thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,221,773 | Benzamide derivatives In force · From the USPTO record | In force | From the USPTO record | |
| US 8,987,468 | Compounds, Pharmaceutical Compositions and Methods of Use of Hydroxamic Acid Derivatives In force · High confidence | In force | High confidence | |
| US 10,392,402 | Heterocyclic compounds as kinase inhibitors In force · From the USPTO record | In force | From the USPTO record | |
| US 10,633,393 | Heterocyclic compounds as kinase inhibitors In force · From the USPTO record | In force | From the USPTO record | |
| US 10,881,733 | Benzamide and active compound compositions and methods of use In force · From the USPTO record | In force | From the USPTO record | |
| US 10,738,007 | Amide compounds as kinase inhibitors, compositions and methods of treatment In force · From the USPTO record | In force | From the USPTO record | |
| US 10,780,080 | Benzamide and active compound compositions and methods of use In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 14: 1 patent in force now held by others · 5 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 4 no status recorded